Medication, Therapy or Both? What the Evidence Says for Depression and Anxiety

For moderate to severe depression, the strongest evidence favors combining psychotherapy with an antidepressant: in pooled trials, the combination helped more people respond than either treatment alone. For milder depression, a structured psychological approach is usually the sensible first step, and medication is one option among several rather than the default.

For generalized anxiety disorder, cognitive behavioral therapy (CBT) and medication, starting with an SSRI, are both first-line in UK guidance, and the choice can rest on your preference. The difference shows up later: the benefits of therapy tend to last after treatment ends, while stopping medication raises the chance of relapse.

The short answer by severity

Guidelines sort depression by how severe it is, because the balance of benefit and burden changes with severity. The UK's National Institute for Health and Care Excellence (NICE) groups subthreshold and mild depression as "less severe" and moderate and severe depression as "more severe," using a PHQ-9 score of 16 as one marker of the dividing line. The American Psychological Association's 2019 guideline, which covers the full range of adult depression, recommends offering either psychotherapy or a second-generation antidepressant through shared decision-making.

What the combined-treatment research shows

The largest comparison to date is a 2020 network meta-analysis led by Pim Cuijpers in World Psychiatry. It pooled 101 randomized trials with 11,910 patients, most with moderate to severe depression. Combined treatment was more effective than psychotherapy alone (relative risk 1.27) and than medication alone (relative risk 1.25) for achieving response, defined as at least a 50% drop in symptoms. Psychotherapy alone and medication alone did not differ from each other.

The same paper found that combined treatment and psychotherapy alone were both more acceptable than medication alone, meaning fewer people dropped out. The authors judged combined treatment the preferred option for patients with moderate depression, while calling for more research on long-term effects and cost.

An earlier meta-analysis of 52 studies looked at adding psychotherapy to antidepressants in both depression and anxiety disorders. Combined treatment was better than medication alone for major depression, panic disorder and obsessive-compulsive disorder, and the advantage was still present up to two years after treatment.

These are averages across many trials. They tell you which strategy gives better odds for a group of people, not what will happen to you. Trial populations also differ from real clinics: people with complicated medical conditions, substance use or bipolar features are often excluded.

Staying well, not only getting well

Depression often returns, so the question is not only which treatment helps first but which keeps you well. A 2021 network meta-analysis of 81 trials and 13,722 participants followed people through a maintenance phase. Both combined treatment and psychotherapy alone produced more sustained response than medication alone.

A smaller meta-analysis of nine studies compared people who finished a course of CBT with people treated with medication. Those who had CBT were less likely to relapse than those whose medication was stopped, and they did about as well as people who kept taking medication. The authors cautioned that the number of studies was small.

For anxiety disorders, a 2017 BMJ meta-analysis of 28 relapse-prevention trials looked at people who had responded to an antidepressant. Relapse within the follow-up period was about 36% in those switched to placebo, compared with about 16% in those who continued the medication. That is a reason to plan how and when medication will eventually be reduced, with your prescriber, rather than a reason to avoid it. The site's guide to discontinuing long-term medication covers that process.

NICE's relapse-prevention advice reflects this. For people who recovered on an antidepressant alone but are at higher risk of relapse, it suggests considering continuing the medication, or a course of group CBT or mindfulness-based cognitive therapy (MBCT) for those who do not wish to continue, or both together. For chronic depressive symptoms that significantly impair functioning in people who have not been treated before, the options it lists include CBT, an antidepressant, or a combination of CBT and an antidepressant (an SSRI or a tricyclic). MBCT for preventing depression relapse explains how that therapy works.

Why therapy is often the first step for mild depression

For less severe depression, NICE lists guided self-help first because it is the least intrusive option, followed by group CBT, group behavioral activation, individual CBT, individual behavioral activation, group exercise and several other options. The guideline says all of these can be first-line choices and that the decision should reflect your preferences.

The APA guideline found similar effects across several therapy models, including behavioral therapy, cognitive and cognitive behavioral therapy, mindfulness-based cognitive therapy, interpersonal psychotherapy, psychodynamic therapies and supportive therapy. In practice, the fit with the therapist and the method matters as much as the label. Coaching, therapy and psychiatry also solve different problems, and it helps to know which one you are looking for.

The site's guide to therapy for depression and how to pick the right fit covers the types in more depth.

When medication earns its place

Medication makes more sense as severity rises, when symptoms such as poor sleep, appetite loss or slowed thinking make it hard to engage in therapy, when depression has come back several times, or when you have responded well to a medication before. NICE notes that therapy sessions can provide support while medication takes time to work, or medication can start first with CBT added as soon as possible.

Medication has trade-offs. NICE lists possible side effects, and the difficulty some people have stopping antidepressants, as points to weigh. The site's article on what antidepressants really do and how to decide explains the effects in detail, and how a first antidepressant is chosen covers the differences between drug classes.

Never start, stop or change a psychiatric medication on your own. Talk with the clinician who prescribes it, who can help you weigh the options and plan any change safely.

What combined care looks like day to day

Combined treatment works best when the two parts are coordinated rather than running in parallel. The prescriber tracks symptoms, side effects and dose; the therapist works on skills, patterns and the situations that keep symptoms going. With your written permission, the two clinicians can share what they are seeing, so a change in sleep noticed in therapy, or a dose change made by the prescriber, does not surprise the other.

If you already have a therapist you trust, you do not need to start over to add medication. Keeping your therapist while seeing a psychiatrist explains how that arrangement usually works, and what to ask both clinicians at the start.

Where lifestyle and complementary approaches fit

Many people want to know whether exercise, light, supplements or other approaches can stand in for therapy or medication. The APA guideline addressed this for adults whose psychotherapy or medication was ineffective or unacceptable. It suggested exercise or St. John's wort on their own as options, and if neither was acceptable or available, bright light therapy or yoga, all as conditional recommendations. It found insufficient evidence to recommend omega-3 fatty acids alone, omega-3 added to an antidepressant, tai chi or SAMe.

Two cautions apply. These were suggestions for people for whom the main treatments had not worked or were not acceptable, not first-line replacements for them. And any supplement, including St. John's wort, belongs in a conversation with your prescriber before you start it, so it can be checked against everything else you take. Bring the bottles to your visit, including vitamins and anything you take only occasionally.

What the evidence does not tell you

• Which therapist will suit you. Trials compare methods, but the fit with an individual clinician is hard to study and still matters.
• How you personally will respond. Pooled results describe groups; your history of past treatments is often a better guide.
• The long-term picture beyond a few years. Most trials follow people for months, and the longer-term studies are fewer and smaller.
• How to treat complicated situations. People with several conditions at once, substance use or bipolar features are often excluded from trials, as noted above.

None of this makes the evidence less useful. It means the averages should start the conversation with your clinician, not end it.

Questions to ask your clinician

1. How severe would you say my symptoms are, and how does that change what you recommend?
2. What specific type of therapy would you suggest, and how many sessions would it usually take?
3. If you suggest medication, what should I expect in the first few weeks, and when will we review it?
4. What would make you suggest combining the two?
5. How long would I likely continue, and how would we plan stopping when the time comes?
6. What should I do if things get worse between visits?

Common mistakes when choosing

1. Judging a treatment too early. An antidepressant may need several weeks before its effect is clear, and therapy often feels harder before it feels better.
2. Stopping medication as soon as you feel well. The relapse data above is the reason to plan any reduction with your prescriber instead.
3. Treating "therapy" as one thing. The evidence is strongest for specific, structured approaches matched to the condition, such as ERP for OCD or trauma-focused therapy for PTSD.
4. Choosing a plan you cannot keep up. A weekly therapy schedule that you cannot attend, or a medication you are reluctant to take, will not help much.
5. Not telling either clinician about the other. Combined care works best when it is coordinated.

Your preference is part of the evidence

Both guidelines put shared decision-making at the center. The APA recommends choosing initial treatment in the context of shared decision-making with the patient, and NICE asks clinicians to match the choice to your clinical needs and preferences. This is not politeness. People are more likely to stay with a treatment they chose, and a treatment that is not used does not help.

Practical factors count too: whether you can reliably attend weekly sessions, what you can afford, whether you are pregnant or planning to be, other medical conditions, and past experience with either approach. A clinician who explains these trade-offs and invites your view is doing the job well.

• Therapy first is reasonable if your symptoms are mild, you prefer to avoid medication, and you can commit to regular sessions.
• Medication first may make sense if symptoms are severe enough that therapy is hard to use, or you have done well on a medication before.
• Ask about combining them if depression is moderate or severe, has lasted a long time, or has returned after earlier treatment.

Anxiety: two first-line paths

For generalized anxiety disorder that has not improved with lower-intensity help, NICE recommends a choice between a high-intensity psychological treatment and drug treatment. The psychological options are CBT or applied relaxation, usually over 12 to 15 weekly sessions; the drug option starts with an SSRI. The guideline bases the choice on preference because it found no evidence that either is better. The related article on anxiety treatment options compares medications, including when benzodiazepines are and are not appropriate.

If anxiety and depression occur together, the combined-treatment evidence for depression applies, and the plan should address both.

Other anxiety-related conditions: the first-line options differ

"Anxiety" covers several conditions, and the guidance on therapy versus medication is not the same for each. NICE's recommendations for adults, summarized below, show how much the answer depends on the diagnosis.

These are UK recommendations; US guidelines and FDA approvals differ in places, and your clinician will tailor the plan. Each condition has its own guide: social anxiety treatment, OCD treatment options, CPT, prolonged exposure and EMDR for PTSD and panic disorder treatment.

Typical time frames

Part of choosing is knowing what each path asks of you, and when you can expect to judge it.

These are typical courses, not limits. Some people need longer, and therapy for longer-standing problems is often extended. How long therapy takes goes through timelines by condition.

Special situations

Teenagers

The APA guideline treats adolescents separately. For initial treatment it recommends CBT or interpersonal psychotherapy adapted for adolescents, names fluoxetine as the first-line medication when medication is considered for major depression, and found insufficient evidence to favor either psychotherapy or fluoxetine over the other. Antidepressant labels carry a Boxed Warning that these medications increased the risk of suicidal thoughts and behaviors in children and young adults in short-term studies, with close monitoring advised for everyone who takes them. A parent's guide to teen depression treatment covers the decision in detail.

Older adults

For adults aged 60 and over, the APA panel recommended group life review or group CBT over no treatment, and combined antidepressant medication with interpersonal psychotherapy over interpersonal psychotherapy alone, preferring a second-generation antidepressant because of its side-effect profile. Other medications and medical conditions make coordination with primary care especially important; see psychiatric care for an aging parent.

A history of mania or hypomania

Antidepressant labels tell prescribers to screen for a personal or family history of bipolar disorder, mania or hypomania before starting, because an antidepressant may trigger a manic or mixed episode in someone with bipolar disorder. Tell your clinician about any past periods of unusually high energy or little need for sleep. Bipolar depression is treated differently; see bipolar depression treatment options.

Pregnancy and the postpartum period

Pregnancy, plans to conceive and breastfeeding change the balance for medication and can change how therapy and medication are weighed. These decisions are individual and belong with your prescriber and obstetric clinician; psychiatric medications during pregnancy and postpartum depression treatment lay out the questions.

If what you are doing is not helping

NICE suggests reviewing the plan if depression has not responded at all after four weeks of medication at a therapeutic dose, or after four to six weeks of psychological therapy or combined treatment. A review looks at adherence, side effects, life stressors and whether the diagnosis is right before changing course. Signs your treatment isn't working explains how to raise this, and the full map of depression treatment options shows what comes next.

If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

At this practice, the team includes psychiatrists, psychiatric nurse practitioners and psychotherapists, so medication management and psychotherapy (including CBT and DBT) are both available within one team, along with coaching, lab testing, and nutrition and lifestyle psychiatry. Care starts with a free discovery call and the Patient Interest Form. For the other ways to begin, see the Choosing Psychiatric Care guide.

Frequently asked questions

Is therapy as effective as antidepressants for depression?

In pooled trials, psychotherapy alone and medication alone produced similar response rates for adult depression, and combining them did better than either. Individual results vary, so the choice depends on severity, preference and history.

Can I start with therapy and add medication later?

Yes. Many people start with therapy, especially for milder depression, and add medication if progress stalls. The reverse also happens: medication first, with therapy added once symptoms ease enough to use it. Discuss timing with your clinician.

Does doing therapy make medication less effective?

No. Research suggests the effects of medication and psychotherapy are largely independent and add to each other.

If I take medication for anxiety, will I need it forever?

Not necessarily. Relapse is more likely after stopping, so the timing and pace of any reduction should be planned with your prescriber. CBT skills can make it easier to stay well over time.

What if I cannot find or afford weekly therapy?

Guided self-help programs based on CBT or behavioral activation are a recognized first step for milder depression. For more severe symptoms, talk with a clinician about what combination is realistic for you.

How long will I need to stay on an antidepressant?

It varies. UK guidance tells people that treatment might need to continue for at least 6 months after symptoms remit, with regular review, and longer for people at higher risk of relapse. Any change should be planned with your prescriber.

Is the advice different for teenagers?

Yes. For adolescents, the APA guideline recommends CBT or interpersonal therapy adapted for adolescents, and fluoxetine as the first-line medication when medication is considered. Parents should be involved in the decision.

Does the right choice depend on which anxiety disorder I have?

Yes. Social anxiety, OCD, PTSD and panic disorder each have their own first-line therapies, and the place of medication differs between them. A clear diagnosis comes first.

Sources

1. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry (Cuijpers et al.), 2020. pubmed.ncbi.nlm.nih.gov
2. Depression in adults: treatment and management (NG222), Recommendations. National Institute for Health and Care Excellence, 2022. nice.org.uk
3. Generalised anxiety disorder and panic disorder in adults: management (CG113), Recommendations. National Institute for Health and Care Excellence, 2011. nice.org.uk
4. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open (Cuijpers et al.), 2013. pubmed.ncbi.nlm.nih.gov
5. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ (Batelaan et al.), 2017. pubmed.ncbi.nlm.nih.gov
6. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. American Psychological Association, 2019. apa.org
7. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry (Cuijpers et al.), 2014. pubmed.ncbi.nlm.nih.gov
8. Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis. World Psychiatry (Furukawa, Cuijpers et al.), 2021. pubmed.ncbi.nlm.nih.gov
9. Social anxiety disorder: recognition, assessment and treatment (CG159), Recommendations. National Institute for Health and Care Excellence, 2013. nice.org.uk
10. Post-traumatic stress disorder (NG116), Recommendations. National Institute for Health and Care Excellence, 2018. nice.org.uk
11. Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31), Recommendations. National Institute for Health and Care Excellence, 2005. nice.org.uk
12. Zoloft (sertraline hydrochloride) prescribing information. Pfizer / DailyMed (NLM), 2025. dailymed.nlm.nih.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.